Related references
Note: Only part of the references are listed.Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer
Ludek Zavesky et al.
REPRODUCTIVE SCIENCES (2019)
MicroRNA-204 inhibits cell migration and invasion in human cervical cancer by regulating transcription factor 12
Longwen Shu et al.
ONCOLOGY LETTERS (2018)
Cancer Screening in the United States, 2018: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Diagnostic and Prognostic Potential of microRNAs in Epithelial Ovarian Carcinoma
Priya Samuel et al.
MOLECULAR DIAGNOSIS & THERAPY (2017)
Clinical outcome and prognostic factors of patients with early-stage epithelial ovarian cancer
Wei Wei et al.
ONCOTARGET (2017)
Updates and current challenges in microRNA research for personalized medicine in ovarian cancer
Victoria Mandilaras et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition
Pui-Wah Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
miR-204 regulates the biological behavior of breast cancer MCF-7 cells by directly targeting FOXA1
Si-Qiao Shen et al.
ONCOLOGY REPORTS (2017)
miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2
Zhengliang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Molecular bases of aberrant miR-182 expression in ovarian cancer
Barbara Marzec-Kotarska et al.
GENES CHROMOSOMES & CANCER (2016)
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Dag Andre Nymoen et al.
HUMAN PATHOLOGY (2016)
miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2
Kaiyao Hua et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination
Lan G. Coffman et al.
TRANSLATIONAL RESEARCH (2016)
Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers
L. Zavesky et al.
NEOPLASMA (2016)
Data Normalization Strategies for MicroRNA Quantification
Heidi Schwarzenbach et al.
CLINICAL CHEMISTRY (2015)
Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma
Jun Zhou et al.
ONCOLOGY REPORTS (2015)
Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study
Ludek Zavesky et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal
Valentina Lulli et al.
ONCOTARGET (2015)
New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers
L. Zavesky et al.
NEOPLASMA (2015)
Programmed Cell Death 4 and MicroRNA 21 Inverse Expression Is Maintained in Cells and Exosomes From Ovarian Serous Carcinoma Effusions
Rocco Cappellesso et al.
CANCER CYTOPATHOLOGY (2014)
Exosome-derived miRNAs and ovarian carcinoma progression
Olga Vaksman et al.
CARCINOGENESIS (2014)
The bright side of ascites in ovarian cancer
Marie Cohen et al.
CELL CYCLE (2014)
Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient
Ye-Won Chung et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer
Shaosheng Wang et al.
MEDICAL ONCOLOGY (2013)
The Impact of Hemolysis on Cell-Free microRNA Biomarkers
Michaela B. Kirschner et al.
Frontiers in Genetics (2013)
Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models
Mara P. Steinkamp et al.
FRONTIERS IN ONCOLOGY (2013)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps et al.
NATURE REVIEWS CANCER (2013)
Causes and Consequences of MicroRNA Dysregulation
Marilena V. Iorio et al.
CANCER JOURNAL (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
Zhaojian Liu et al.
JOURNAL OF PATHOLOGY (2012)
Targeting Immune Checkpoints Releasing the Restraints on Anti-Tumor Immunity for Patients With Melanoma
Michael A. Postow et al.
CANCER JOURNAL (2012)
miRNA profiling along tumour progression in ovarian carcinoma
Olga Vaksman et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Ovarian cancer: Origin and factors involved in carcinogenesis with potential use in diagnosis, treatment and prognosis of the disease
L. Zavesky et al.
NEOPLASMA (2011)
Early Diagnosis of Ovarian Carcinoma: Is a Solution in Sight?
Amelie M. Lutz et al.
RADIOLOGY (2011)
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Jan Hellemans et al.
GENOME BIOLOGY (2007)
Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations
MW Pfaffl et al.
BIOTECHNOLOGY LETTERS (2004)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Share Paper
